Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center
Abstract Background Palliative sedation (PS) is an intervention to treat refractory symptoms and to relieve suffering at the end of life. Its prevalence and practice patterns vary widely worldwide. The aim of our study was to evaluate the frequency, clinical indications and outcomes of PS in advance...
Main Authors: | Bernard Lobato Prado, Diogo Bugano Diniz Gomes, Pedro Luiz Serrano Usón Júnior, Patricia Taranto, Monique Sedlmaier França, Daniel Eiger, Rodrigo Coutinho Mariano, David Hui, Auro Del Giglio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | BMC Palliative Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12904-017-0264-2 |
Similar Items
-
Midazolam sedation in palliative medicine: retrospective study in a French center for cancer control
by: Vincent Gamblin, et al.
Published: (2020-06-01) -
Midazolam en la sedación paliativa terminal de pacientes con cáncer Midazolam in the terminal palliative sedation in patients with cancer
by: Jorge Luis Soriano García, et al.
Published: (2011-12-01) -
Palliative sedation challenging the professional competency of health care providers and staff: a qualitative focus group and personal written narrative study
by: Danièle Leboul, et al.
Published: (2017-04-01) -
Comparison of Hemodynamic and Sedation Effects of Midazolam and Propofol
by: Şermin Eminoğlu, et al.
Published: (2015-03-01) -
Intramuscular compared to intravenous midazolam for paediatric sedation: A study on cardiopulmonary safety and effectiveness
by: Mohammad-Reza Ghane, et al.
Published: (2014-01-01)